Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.552EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.429EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.373EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.242EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.449EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.152EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.146EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.21 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.338EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.20.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.562EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used